Abstract
A metal-organic framework (MOF) medi-MOF-1 containing curcumin with inhibitory effect on tumor growth was adopted for cancer therapy. And theranostic agents Mn ions were loaded to construct a theranostic system Mn@medi-MOF-1 (Mn 14.82 wt% and curcumin 31.62 wt%). In vitro, it displayed T1-weighted magnetic resonance performance, ideal ability of ROS production for chemodynamic therapy and stimuli-responsive drug release to inhibit cancer cell growth, indicating its potential applications for multimodal cancer theranostic.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
